Monday, Protalix BioTherapeutics, Inc. (PLX) revealed the appointment of Aaron Ciechanover to its scientific advisory board. Ciechanover had been honored with a Nobel Prize in Chemistry.
Ciechanover is currently a research professor at the Cancer and Vascular Biology Research Center of the Rappaport Research Institute and Faculty of Medicine at the Technion.
For comments and feedback: editorial@rttnews.com